Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section — Stella

Home/Postsurgical Pain/

View on ClinicalTrials.gov

Recruiting

Back to Postsurgical Pain trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Taiwan

Dalin Tzu Chi Hospital, Dalin, Chai-Yi

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Dalin Tzu Chi General Hospital

Enrollment target

~120 participants

Started

May 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years and older

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.